New Immuno-Onco Deal With Merck KGaA Could Make This UK Biotech a $1 Billion Company

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815×450-deal3.jpg" NAME"New Immuno-Onco Deal With Merck KGaA Could Make This UK Biotech a $1 Billion Company" ALT"New Immuno-Onco Deal With Merck KGaA Could Make This UK Biotech a $1 Billion Company"June 5, 2017By Alex Keown, BioSpace…
Source: BioSpace